Anavex Life Sciences
AVXL
#9438
Rank
ยฃ0.10 B
Marketcap
ยฃ1.14
Share price
1.34%
Change (1 day)
-82.32%
Change (1 year)

Anavex Life Sciences (AVXL) - Net assets

Net assets on the balance sheet as of June 2026 : ยฃ85.13 Million

According to Anavex Life Sciences 's latest financial reports the company has ยฃ85.13 Million in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Anavex Life Sciences - Net assets on balance sheet (from 2005 to 2026)

Net assets by year

Year Net assets Change
2025-09-30$ยฃ70.56 M-21.51%
2024-09-30$ยฃ89.9 M-22.69%
2023-09-30$ยฃ0.11 B-9.18%
2022-09-30$ยฃ0.12 B14.37%
2021-09-30$ยฃ0.11 B431.03%
2020-09-30$ยฃ21.08 M27.72%
2019-09-30$ยฃ16.5 M-3.56%
2018-09-30$ยฃ17.11 M-5.44%
2017-09-30$ยฃ18.1 M272.01%
2016-09-30$ยฃ4.86 M-42.54%
2015-09-30$ยฃ8.46 M7028.81%
2014-09-30$ยฃ0.11 M-107.81%
2013-09-30$-ยฃ1.53 Million-14.66%
2012-09-30$-ยฃ1.79 Million143.76%
2011-09-30$-ยฃ0.74 Million-61.16%
2010-09-30$-ยฃ1.89 Million-22.36%
2009-09-30$-ยฃ2.43 Million87.33%
2008-09-30$-ยฃ1.3 Million472.43%
2007-09-30$-ยฃ0.23 Million2630.95%
2006-09-30$-ยฃ0.01 Million-43.92%
2005-09-30$-ยฃ0.02 Million-203.79%
2004-09-30$ยฃ0.01 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Ligand Pharmaceuticals
LGND
ยฃ0.73 B 760.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Corcept Therapeutics
CORT
ยฃ0.53 B 527.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
ยฃ8.01 M-90.58%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-ยฃ0.35 Billion-504.00%๐Ÿ‡บ๐Ÿ‡ธ USA